NCT02525640

Brief Summary

Single sided deafness (SSD) refers to asymmetrical hearing loss, where there is a significant worsening of hearing in one ear compared to the other. In Cambridge, the investigators see large numbers of patients with SSD caused by vestibular schwannomas, due to their affiliation with the Neuro-Otology Department, with over 100 new SSD patients being referred every year. Only a small number of studies have explored hearing handicap for those with SSD, and music appreciation has not been investigated, to the best of the investigators knowledge, in this patient group. In the limited number of studies conducted on those with single sided deafness, often only one or two outcome measures have been used, or the patient group has been small. The investigators have a large group of patients with a wide range of aetiologies who have completed several questionnaires as part of their treatment in the single sided deafness clinic and the investigators would like to analyse these data. At present there are different devices available on the NHS for the management of SSD and many studies have explored benefits of Bone Anchored Hearing Aids (BAHA). There is an under-representation of studies looking specifically at CROS aid devices which is relevant given the cost differences involved between devices. Study goals and objectives

  • To find out what factors drive hearing handicap in SSD patients by analysing the results of several different well validated hearing handicap questionnaires
  • To find out whether or not it is possible to change hearing handicap in this patient group by looking to see if there is an improvement in questionnaire scores post treatment.
  • The investigators will also look at a sub-group who will be fitted with both traditional wired CROS aids and more up-to-date wireless aids which have been funded through a research grant, in order to assess whether these are more beneficial.
  • The investigators will use a new questionnaire developed in-house to further explore the impact of single sided deafness on music appreciation.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2014

Completed
11 months until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 17, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

April 7, 2017

Status Verified

April 1, 2017

Enrollment Period

1.5 years

First QC Date

September 3, 2014

Last Update Submit

April 6, 2017

Conditions

Keywords

Single sided hearing lossSingle sided deafnessHearing loss music appreciation

Outcome Measures

Primary Outcomes (5)

  • Abbreviated hearing aid benefit profile (APHAB)

    Hearing aid benefit questionnaire

    180 days

  • Speech and spatial qualities of hearing (SSQ)

    Hearing aid benefit questionnaire

    180 days

  • Tinnitus handicap inventory (THI)

    Tinnitus questionnaire

    180 days

  • Hearing handicap inventory (HHI)

    Hearing aid benefit questionnaire

    180 days

  • Hospital anxiety and depression scale (HADS)

    Anxiety and depression questionnaire

    180 days

Study Arms (1)

Hearing Aid

EXPERIMENTAL

CROS hearing aid

Device: Hearing Aid

Interventions

Hearing aid comparison

Also known as: Phonak Nathos S+ Micro Wireless CROS aid, Oticon Spirit Zest Wired CROS aid
Hearing Aid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who attend the single sided deafness clinic.
  • Must have either no recordable hearing threshold levels on one side or a significant asymmetry.
  • The 13 CROS aid trial patients must be post-operative vestibular schwannoma patients with an audiological 'dead ear' on the affected side.

You may not qualify if:

  • Patients unable to give informed consent
  • Patients under 18 years of age
  • For the CROS aid trial, patients with any aetiology other than vestibular schwanomma, pre-operative vestibular schwanomma patients or vestibular schwanomma patents who still have residual hearing in the affected ear.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cambridge University Hospital NHS Trust, Audiology department

Cambridge, Cambridgeshire, CB7 5TT, United Kingdom

Location

MeSH Terms

Conditions

Hearing Loss

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Study Officials

  • Mark D Smith, MSc

    Addenbrooke's Hospital, Cambridge, UK

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist Audiologist

Study Record Dates

First Submitted

September 3, 2014

First Posted

August 17, 2015

Study Start

August 1, 2015

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

April 7, 2017

Record last verified: 2017-04

Locations